You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

focal segmental glomerulosclerosis (FSGS)

Showing 1 - 25 of 1,526
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Focal Segmental Glomerulosclerosis and Minimal Change Disease

Not yet recruiting
  • Focal Segmental Glomerulosclerosis
  • +3 more
  • Biospecimen collection
  • Data collection
  • Ann Arbor, Michigan
    University of Michigan
Dec 6, 2022

LDL-Apheresis for FSGS CardioRenal Outcomes

Enrolling by invitation
  • Focal Segmental Glomerulosclerosis
  • No intervention
  • Cincinnati, Ohio
  • +1 more
Jan 25, 2023

Focal Segmental Glomerulosclerosis Trial (Metformin + Standard of Care, Placebo + Standard of Care)

Not yet recruiting
  • Focal Segmental Glomerulosclerosis
  • Metformin + Standard of Care
  • Placebo + Standard of Care
  • (no location specified)
Oct 13, 2023

Focal Segmental Glomerulosclerosis (FSGS) Trial (VX-147)

Not yet recruiting
  • Focal Segmental Glomerulosclerosis (FSGS)
  • (no location specified)
Jul 13, 2023

Focal Segmental Glomerulosclerosis (FSGS) Trial (IXP)

Not yet recruiting
  • Focal Segmental Glomerulosclerosis (FSGS)
  • (no location specified)
May 9, 2023

Minimal Change Disease, Focal Segmental Glomerulosclerosis Trial in United States (VB119)

Recruiting
  • Minimal Change Disease
  • Focal Segmental Glomerulosclerosis
  • Los Angeles, California
  • +7 more
Jul 19, 2022

Focal Segmental Glomerulosclerosis Trial in Australia (Propagermanium, Placebo)

Completed
  • Focal Segmental Glomerulosclerosis
  • Gosford, New South Wales, Australia
  • +10 more
Jul 28, 2022

Humanistic Burden of Focal Segmental Glomerulosclerosis and IgAN

Recruiting
  • Focal Segmental Glomerulosclerosis
  • Immunoglobulin A Nephropathy
    • Belmar, New Jersey
    • +2 more
    Apr 12, 2022

    FSGS, MCD, Focal Segmental Glomerulosclerosis Trial in United States (adalimumab)

    Recruiting
    • FSGS
    • +3 more
    • Ann Arbor, Michigan
    • +3 more
    Jan 31, 2022

    Primary Focal Segmental Glomerulosclerosis Trial in Rochester (Obinutuzumab)

    Recruiting
    • Primary Focal Segmental Glomerulosclerosis
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Dec 13, 2021

    Focal Segmental Glomerulosclerosis (FSGS) Trial in Worldwide (PF-06730512)

    Active, not recruiting
    • Focal Segmental Glomerulosclerosis (FSGS)
    • Birmingham, Alabama
    • +59 more
    Aug 17, 2022

    Genetic Markers for Focal Segmental Glomerulosclerosis

    Completed
    • Focal Segmental Glomerulosclerosis
    • HIV-Associated Focal Segmental Glomerulosclerosis
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 26, 2023

      Focal Segmental Glomerulosclerosis Trial in United States (Rituximab, Plasmapheresis)

      Recruiting
      • Focal Segmental Glomerulosclerosis
      • Tuscaloosa, Alabama
      • +13 more
      Nov 16, 2021

      Focal Segmental Glomerulosclerosis Trial in Dominican Republic, United States (Voclosporin)

      Terminated
      Has Results
      • Focal Segmental Glomerulosclerosis
      • Denver, Colorado
      • +22 more
      Aug 20, 2021

      Adult and Child Patients and Parents of Swelling Due to

      Recruiting
      • Fluid Overload
      • +12 more
      • Interview
      • Ann Arbor, Michigan
        University of Michigan
      Aug 16, 2022

      Understand Genetics and Clinical Course of Focal Segmental

      Terminated
      • Glomerulosclerosis, Focal Segmental
      • +2 more
      • FSGS/TR-MCD
      • Diabetic Nephropathy (DN)
      • Mesa, Arizona
      • +17 more
      Jul 17, 2021

      NEPTUNE Match Study

      Enrolling by invitation
      • Nephrotic Syndrome in Children
      • +7 more
      • Communication
      • Atlanta, Georgia
      • +15 more
      Jan 30, 2023

      FSGS Trial in Washington (Acthar)

      Recruiting
      • FSGS
      • Washington, District of Columbia
        Medstar Georgetown Transplant Institute
      Dec 10, 2020

      Nephrotic Syndrome, Focal Segmental Glomerulosclerosis, Minimal Change Disease Trial in United States (Abatacept, Normal Saline,

      Completed
      Has Results
      • Nephrotic Syndrome
      • +2 more
      • Birmingham, Alabama
      • +26 more
      Feb 10, 2021

      Alport Syndrome, Focal Segmental Glomerulosclerosis Trial in United States (R3R01)

      Recruiting
      • Alport Syndrome
      • Focal Segmental Glomerulosclerosis
      • Los Angeles, California
      • +10 more
      Aug 15, 2022

      Glomerulosclerosis, Focal Segmental, Minimal Change Disease, Idiopathic Nephrotic Syndrome Trial in Cologne (Biosampling)

      Recruiting
      • Glomerulosclerosis, Focal Segmental
      • +2 more
      • Biosampling
      • Cologne, NRW, Germany
        University Hospital of Cologne
      Nov 12, 2021

      FSGS, Focal Segmental Glomerulosclerosis, Glomerulosclerosis Trial in Worldwide (Placebo, CCX140-B)

      Completed
      • FSGS
      • +2 more
      • Phoenix, Arizona
      • +37 more
      Apr 2, 2021

      Primary Focal Segmental Glomerulosclerosis Trial in United States (CXA-10)

      Completed
      • Primary Focal Segmental Glomerulosclerosis
      • Huntsville, Alabama
      • +23 more
      Jul 31, 2020

      Focal Segmental Glomerulosclerosis Trial in United States (LIPOSORBER® LA-15 System)

      Recruiting
      • Focal Segmental Glomerulosclerosis
      • LIPOSORBER® LA-15 System
      • Loma Linda, California
      • +11 more
      Mar 28, 2022

      Focal Segmental Glomerulosclerosis Trial in Worldwide (sparsentan, Irbesartan)

      Active, not recruiting
      • Focal Segmental Glomerulosclerosis
      • Mesa, Arizona
      • +224 more
      Oct 27, 2022